Corporate/M&A (PRC Firms) - China
What the team is known for
FenXun Partners has a proven track record in the market for its handling of complex inbound and outbound M&A projects. It routinely advises multinationals on the corporate law aspects of their business operations in China, including companies from the chemical and mechanical engineering sectors. The firm is part of a joint operation with Baker McKenzie, which afford it access to a global network of offices and expertise. The team acts for clients such as Koch Engineered Solutions, IGM Financial and Ganfeng Lithium Group.
Strengths
"They are fully flexible, possess great knowledge and are patient in searching for a balanced solution."
"The team works hard and can always meet our expectations while adhering to a timeline."
Work highlights
FenXun Partners acted for Johnson & Johnson in the demerger of its consumer health business in preparation for separate stock market listing.
Notable practitioners
Cherrie Shi, Ruan Zhenyu and Zhang Hong are the key contacts for the practice.
业务优势
奋迅律师事务所在处理复杂的境内外并购项目方面拥有良好的市场业绩。该所经常为跨国公司(包括化学和机械工程行业的公司)在中国业务运营的公司法方面提供咨询。该所是与贝克·麦坚时联营的一部分,使其能够利用全球办事处网络和专业知识。该团队为科氏工业集团、IGM Financial 和赣锋锂业集团等客户提供服务。
市场评价
“他们非常灵活,拥有丰富的知识,并且耐心地寻找平衡的解决方案。”
“团队工作努力,总能满足我们的期望,同时遵守时间表。”
业务亮点
奋迅律师事务所代理强生公司分拆其消费者健康业务,准备单独上市。
领先律师
施淼律师、阮振宇律师和张宏律师是该业务的关键联系人。